Medicare Enrolled
Dr. Muhammed Ali, MD
Cardiovascular Disease · Amarillo, TX
Practice pattern: Electrophysiology & Remote— Practice combining electrophysiology and remote services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ali from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ali? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ali
Dr. Muhammed Ali is a cardiovascular disease in Amarillo, TX, with 19 years in practice. Based on federal Medicare data, Dr. Ali performed 9,399 Medicare services across 4,931 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ali received a total of $48,422 from 33 pharmaceutical and/or device companies across 629 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ali is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 4% volume in TX$ $48,422 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,399
Medicare services
Top 4% in TX for cardiovascular disease
4,931
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~495 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Remote pacemaker/defibrillator monitoring, 90 days | 1,437 | $16 | $75 |
| Electrocardiogram (EKG), 12-lead | 1,198 | $10 | $85 |
| Office visit, established patient (30-39 min) | 1,119 | $91 | $275 |
| Remote pacemaker monitoring, 90 days | 895 | $22 | $165 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 629 | $19 | $175 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 553 | $27 | $200 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 409 | $28 | $150 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 405 | $20 | $100 |
| EKG interpretation and report | 386 | $6 | $53 |
| Anticoagulant management of patient taking warfarin | 314 | $9 | $50 |
| Programming of dual lead pacemaker system | 250 | $56 | $294 |
| Hospital follow-up visit, moderate complexity | 233 | $61 | $175 |
| Echocardiogram, transthoracic | 218 | $143 | $1,401 |
| Office visit, established patient (20-29 min) | 205 | $61 | $200 |
| Prothrombin time test (blood clotting) | 113 | $4 | $32 |
| Chronic care management, first 20 min/month | 113 | $45 | $100 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 108 | $52 | $350 |
| Initial hospital admission, moderate complexity | 98 | $102 | $350 |
| Ultrasound of heart with probe in esophagus, with report | 86 | $83 | $632 |
| Programming of dual lead implantable defibrillator system | 81 | $73 | $260 |
| Programming of multiple lead implantable defibrillator system | 73 | $79 | $265 |
| Evaluation of implantable heart and blood vessel monitoring system | 44 | $30 | $200 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 40 | $378 | $2,730 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 33 | $19 | $100 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 33 | $715 | $2,000 |
| Programming of cardiac rhythm monitor system | 26 | $48 | $165 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 25 | $10 | $220 |
| Insertion of implantable defibrillator system | 22 | $693 | $3,420 |
| Programming of multiple lead pacemaker system | 21 | $63 | $375 |
| Evaluation of single or dual chamber pacing cardioverter-defibrillator and generator at time of implantation or replacement | 21 | $118 | $2,075 |
| New patient office visit (45-59 min) | 21 | $122 | $294 |
| Programming of single lead implantable defibrillator system | 20 | $60 | $205 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 19 | $354 | $1,200 |
| Programming of single lead pacemaker system | 19 | $53 | $260 |
| Evaluation of cardiac rhythm monitor system | 18 | $30 | $147 |
| Removal of heart rhythm monitor from under the skin | 17 | $44 | $1,500 |
| External shock to heart to regulate heart beat | 17 | $84 | $475 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 16 | $228 | $800 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 15 | $620 | $1,487 |
| Office visit, established patient, complex (40-54 min) | 15 | $131 | $375 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 12 | $58 | $500 |
| Cardiac catheterization | 11 | $207 | $3,995 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 11 | $235 | $800 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
39.8% high complexity
2.2% medium
58.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$48,422
Total received (2018-2024)
Avg $6,917/year across 7 years
Top 11% in TX for cardiovascular disease
33
Companies
629
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$48,279 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$143 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$11,370
2023$12,823
2022$8,348
2021$1,510
2020$1,884
2019$7,480
2018$5,005
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$17,911
BIOTRONIK INC.
$9,643
Medtronic, Inc.
$8,331
Medtronic Vascular, Inc.
$7,264
Boston Scientific Corporation
$2,624
E.R. Squibb & Sons, L.L.C.
$347
Novartis Pharmaceuticals Corporation
$315
Biosense Webster, Inc.
$306
Janssen Pharmaceuticals, Inc
$306
AstraZeneca Pharmaceuticals LP
$202
Philips North America LLC
$189
Amarin Pharma Inc.
$115
Novo Nordisk Inc
$108
Philips Electronics North America Corporation
$93
Merck Sharp & Dohme LLC
$93
Edwards Lifesciences Corporation
$89
BOSTON SCIENTIFIC CORPORATION
$82
ABIOMED
$79
Cook Medical LLC
$39
Inspire Medical Systems, Inc.
$35
Amgen Inc.
$32
PFIZER INC.
$31
EKOS Corporation
$27
CARDIVA MEDICAL, INC.
$22
ARBOR PHARMACEUTICALS, INC.
$19
Bayer HealthCare Pharmaceuticals Inc.
$18
Regeneron Healthcare Solutions, Inc.
$16
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
Kowa Pharmaceuticals America, Inc.
$15
Cranial Technologies, Inc
$14
Ultragenyx Pharmaceutical Inc.
$14
Lilly USA, LLC
$14
Medtronic USA, Inc.
$13
Top 3 companies account for 74.1% of total payments
Associated products mentioned in payments ›
(AM5) Lead management · ACCENT · ADVISOR · AGILIS · ASSURITY · AVEIR · AZURE XT DR MRI SURESCAN · Acticor 7 VR-T DX · Advisor Catheter · Allure Quadra RF CRT Pacemaker · Amplia MRI · Arctic Front · Assurity Pacemaker · Azure · BIOMONITOR · BioMonitor · CAMZYOS · CONFIRM RX · Cardiva VASCADE MVP VVCS 6-12F · CareLink · Carto 3 · Carto 3 System · Confirm Rx · Crysvita · Doc Band · EKOSONIC · ELIQUIS · EMBLEM · EMGALITY · ENSITE · ENSITE PRECISION · ENTRESTO · EP-WorkMate Claris System · Edarbyclor · Edora 8 DR-T · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Ellipse ICD · EnSite Precision Cardiac Mapping System · Ensite Cardiac Mapping System · FARXIGA · FORTIFY ASSURA · Fortify Assura · GALLANT · GENERAL THERAPIES · HeartMate · HeartMate 3 Left Ventricular Dev · INSPIRE · Impella · JARDIANCE · JOT DX · Kerendia · LEQVIO · LYNPARZA · Livalo · MICRA · Merlin Connectivity and Remote · Micra · Ozempic · PRALUENT · PULSESELECT · PlasmaBlade · QUADRA ALLURE MP · QUADRA ASSURA · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · Quartet CRT Lead · RESONATE · REVEAL LINQ · RHYTHMIA · Repatha · Reveal LINQ · Rivacor 7 DR-T · Rybelsus · SELECTSECURE · SENSITHERM MULTI · SelectSecure · Solia · TactiCath Quartz CFA Catheter · Tendril Pacing Lead · Trilogy 100 · VANTAGEVIEW · VERQUVO · VantageView System · Vascepa · ViewFlex Xtra ICE Catheter · ViewMate Intracardiac Echo · WATCHMAN · WATCHMAN Access System · Wegovy · XARELTO · ZILVER VENA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $515 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
24
Per 100K population
20.6
County median income
$50,448
Nearest hospital
QUAIL CREEK SURGICAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ali is a electrophysiology & remote specialist, with above-average Medicare volume (top 4% in TX), and high industry engagement (low-engagement, top 11%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ali experienced with remote pacemaker/defibrillator monitoring, 90 days?
Based on Medicare claims data, Dr. Ali performed 1,437 remote pacemaker/defibrillator monitoring, 90 days services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ali receive payments from pharmaceutical companies?
Yes. Dr. Ali received a total of $48,422 from 33 companies across 629 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ali's costs compare to other cardiovascular diseases in Amarillo?
Dr. Ali's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ali) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Amarillo
Browse cardiovascular diseases in Amarillo ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
BIOTRONIK INC. Payments to Doctors
See all physicians who received payments from BIOTRONIK INC..
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology